We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$157M
AUM Growth
-$323M
Cap. Flow
-$292M
Cap. Flow %
-185.79%
Top 10 Hldgs %
79.11%
Holding
47
New
4
Increased
9
Reduced
4
Closed
16

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.13M
2
BABA icon
Alibaba
BABA
+$1.85M
3
C icon
Citigroup
C
+$1.23M
4
ATRS
Antares Pharma, Inc.
ATRS
+$1.03M
5
AMZN icon
Amazon
AMZN
+$954K

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$12.9M
2
GS icon
Goldman Sachs
GS
+$5.99M
3
AAPL icon
Apple
AAPL
+$5.03M
4
WING icon
Wingstop
WING
+$3.28M
5
UNH icon
UnitedHealth
UNH
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 50.52%
2 Consumer Discretionary 15.87%
3 Communication Services 14.16%
4 Technology 3.54%
5 Financials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$41.5M 26.41%
525,755
– –
TSLA icon
2
CALL
Tesla
TSLA
$1.21T
$21.3M 13.58%
885,000
+883,500
+58,900% +$19.4M
AMZN icon
3
Amazon
AMZN
$2.48T
$17M 10.85%
352,260
+20,000
+6% +$954K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.08T
$13.9M 8.88%
300,000
– –
META icon
5
Meta Platforms (Facebook)
META
$1.51T
$8.3M 5.29%
55,000
+5,000
+10% +$743K
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
$5.38M 3.43%
1,671,956
+362,431
+28% +$1.03M
AVDL
7
DELISTED
Avadel Pharmaceuticals
AVDL
$4.9M 3.12%
444,439
– –
MSFT icon
8
Microsoft
MSFT
$2.92T
$4.48M 2.85%
65,000
-45,000
-41% -$3.09M
CMG icon
9
Chipotle Mexican Grill
CMG
$43B
$3.75M 2.38%
450,000
– –
BSTC
10
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.65M 2.32%
73,649
– –
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.21M 2.05%
270,775
-236,300
-47% -$2.94M
CBM
12
DELISTED
Cambrex Corporation
CBM
$3.02M 1.92%
50,519
+5,000
+11% +$281K
NVLN
13
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.92M 1.86%
315,980
+5,681
+2% +$54.7K
ISRG icon
14
Intuitive Surgical
ISRG
$130B
$2.81M 1.79%
27,000
– –
XBI icon
15
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$2.31M 1.47%
+30,000
New +$2.13M
JNP
16
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.16M 1.37%
426,903
+38,771
+10% +$173K
BABA icon
17
Alibaba
BABA
$276B
$2.11M 1.35%
+15,000
New +$1.85M
WYNN icon
18
Wynn Resorts
WYNN
$10.3B
$2.01M 1.28%
15,000
+5,000
+50% +$629K
CPIX icon
19
Cumberland Pharmaceuticals
CPIX
$102M
$1.85M 1.18%
263,881
– –
LGND icon
20
Ligand Pharmaceuticals
LGND
$5.94B
$1.63M 1.04%
21,482
-6,412
-23% -$449K
ANIP icon
21
ANI Pharmaceuticals
ANIP
$1.84B
$1.39M 0.89%
29,722
– –
ALIM
22
DELISTED
Alimera Sciences
ALIM
$1.34M 0.86%
64,400
+8,667
+16% +$186K
C icon
23
Citigroup
C
$222B
$1.34M 0.85%
+20,000
New +$1.23M
BHC icon
24
Bausch Health
BHC
$1.69B
$1.11M 0.71%
+64,150
New +$769K
MU icon
25
Micron Technology
MU
$927B
$1.07M 0.68%
36,000
– –
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, JW Asset Management held 47 positions worth $157M, down 67% from $480M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

JW Asset Management withdrew a net $292M in Q2 2017, closing 16 positions and reducing 4 holdings. Its most notable exit was Tesla, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in State Street SPDR S&P Biotech ETF worth $2.31M.

  • JW Asset Management's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 30,000 shares worth $2.31M.
  • JW Asset Management added most to Antares Pharma, Inc. in Q2 2017, an estimated $1.03M increase.
  • JW Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $3.09M.
  • JW Asset Management fully exited Tesla in Q2 2017, selling an estimated $12.9M.
  • JW Asset Management's ten largest holdings make up 79% of its $157M portfolio in Q2 2017.
  • JW Asset Management opened 4 new positions and closed 16 in Q2 2017.
  • JW Asset Management's portfolio value fell 67% quarter-over-quarter to $157M.

Based on JW Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.